ZOOMD TECHNOLOGIES LTD (ZOMD.CA)

CA98981L1004 - Common Stock

0.95  +0.12 (+14.46%)

Fundamental Rating

5

We assign a fundamental rating of 5 out of 10 to ZOMD. ZOMD was compared to 66 industry peers in the Software industry. While ZOMD has a great health rating, its profitability is only average at the moment. ZOMD is not valued too expensively and it also shows a decent growth rate.



6

1. Profitability

1.1 Basic Checks

In the past year ZOMD was profitable.
In the past year ZOMD had a positive cash flow from operations.
In the past 5 years ZOMD reported 4 times negative net income.
The reported operating cash flow has been mixed in the past 5 years: ZOMD reported negative operating cash flow in multiple years.

1.2 Ratios

ZOMD's Return On Assets of 23.85% is amongst the best of the industry. ZOMD outperforms 98.48% of its industry peers.
With an excellent Return On Equity value of 39.82%, ZOMD belongs to the best of the industry, outperforming 95.45% of the companies in the same industry.
Looking at the Return On Invested Capital, with a value of 24.91%, ZOMD belongs to the top of the industry, outperforming 95.45% of the companies in the same industry.
Industry RankSector Rank
ROA 23.85%
ROE 39.82%
ROIC 24.91%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

ZOMD has a Profit Margin of 12.40%. This is amongst the best in the industry. ZOMD outperforms 87.88% of its industry peers.
The Operating Margin of ZOMD (13.38%) is better than 81.82% of its industry peers.
The Gross Margin of ZOMD (38.16%) is comparable to the rest of the industry.
ZOMD's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 13.38%
PM (TTM) 12.4%
GM 38.16%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y6.32%
GM growth 5YN/A

7

2. Health

2.1 Basic Checks

There is no outstanding debt for ZOMD. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.

2.2 Solvency

ZOMD has an Altman-Z score of 5.98. This indicates that ZOMD is financially healthy and has little risk of bankruptcy at the moment.
ZOMD's Altman-Z score of 5.98 is amongst the best of the industry. ZOMD outperforms 81.82% of its industry peers.
ZOMD has a debt to FCF ratio of 0.59. This is a very positive value and a sign of high solvency as it would only need 0.59 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 0.59, ZOMD belongs to the top of the industry, outperforming 86.36% of the companies in the same industry.
ZOMD has a Debt/Equity ratio of 0.22. This is a healthy value indicating a solid balance between debt and equity.
ZOMD's Debt to Equity ratio of 0.22 is fine compared to the rest of the industry. ZOMD outperforms 60.61% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.22
Debt/FCF 0.59
Altman-Z 5.98
ROIC/WACCN/A
WACCN/A

2.3 Liquidity

ZOMD has a Current Ratio of 1.89. This is a normal value and indicates that ZOMD is financially healthy and should not expect problems in meeting its short term obligations.
ZOMD has a better Current ratio (1.89) than 69.70% of its industry peers.
A Quick Ratio of 1.89 indicates that ZOMD should not have too much problems paying its short term obligations.
Looking at the Quick ratio, with a value of 1.89, ZOMD is in the better half of the industry, outperforming 69.70% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.89
Quick Ratio 1.89

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 188.69% over the past year.
The Revenue has grown by 32.81% in the past year. This is a very strong growth!
ZOMD shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 8.10% yearly.
EPS 1Y (TTM)188.69%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%1314.98%
Revenue 1Y (TTM)32.81%
Revenue growth 3Y8.1%
Revenue growth 5YN/A
Sales Q2Q%134.66%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

5

4. Valuation

4.1 Price/Earnings Ratio

ZOMD is valuated reasonably with a Price/Earnings ratio of 11.88.
Based on the Price/Earnings ratio, ZOMD is valued cheaply inside the industry as 93.94% of the companies are valued more expensively.
ZOMD's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 27.28.
Industry RankSector Rank
PE 11.88
Fwd PE N/A

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, ZOMD is valued cheaper than 86.36% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, ZOMD is valued cheaper than 83.33% of the companies in the same industry.
Industry RankSector Rank
P/FCF 11.79
EV/EBITDA 7.41

4.3 Compensation for Growth

ZOMD has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

ZOMD does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

ZOOMD TECHNOLOGIES LTD

TSX-V:ZOMD (1/14/2025, 7:00:00 PM)

0.95

+0.12 (+14.46%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap0
Analysts0
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 11.88
Fwd PE N/A
P/S 1.48
P/FCF 11.79
P/OCF 11.63
P/B 4.76
P/tB 9.12
EV/EBITDA 7.41
EPS(TTM)0.08
EY8.42%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.08
FCFY8.48%
OCF(TTM)0.08
OCFY8.6%
SpS0.64
BVpS0.2
TBVpS0.1
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 23.85%
ROE 39.82%
ROCE 38.89%
ROIC 24.91%
ROICexc 39.94%
ROICexgc 104.28%
OM 13.38%
PM (TTM) 12.4%
GM 38.16%
FCFM 12.58%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y6.32%
GM growth 5YN/A
F-Score8
Asset Turnover1.92
Health
Industry RankSector Rank
Debt/Equity 0.22
Debt/FCF 0.59
Debt/EBITDA 0.36
Cap/Depr 3.33%
Cap/Sales 0.17%
Interest Coverage 250
Cash Conversion 68.95%
Profit Quality 101.48%
Current Ratio 1.89
Quick Ratio 1.89
Altman-Z 5.98
F-Score8
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)3.34%
Cap/Depr(5y)3.08%
Cap/Sales(3y)0.22%
Cap/Sales(5y)0.22%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)188.69%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%1314.98%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)32.81%
Revenue growth 3Y8.1%
Revenue growth 5YN/A
Sales Q2Q%134.66%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y310.98%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y34.3%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y27.92%
OCF growth 3YN/A
OCF growth 5YN/A